Back to User profile » Dr Haipeng Xu

Papers published by Dr Haipeng Xu:

Corrigendum

LHX6 Affects Erlotinib Resistance and Migration of EGFR-Mutant Non-Small-Cell Lung Cancer HCC827 Cells Through Suppressing Wnt/β-Catenin Signaling [Corrigendum]

Wang Q, Liao J, He Z, Su Y, Lin D, Xu L, Xu H, Lin J

OncoTargets and Therapy 2021, 14:2337-2338

Published Date: 6 April 2021

Corrigendum

LHX6 Affects Erlotinib Resistance and Migration of EGFR-Mutant Non-Small-Cell Lung Cancer HCC827 Cells Through Suppressing Wnt/β-Catenin Signaling [Corrigendum]

Wang Q, Liao J, He Z, Su Y, Lin D, Xu L, Xu H, Lin J

OncoTargets and Therapy 2021, 14:253-254

Published Date: 12 January 2021

Original Research

LHX6 Affects Erlotinib Resistance and Migration of EGFR-Mutant Non-Small-Cell Lung Cancer HCC827 Cells Through Suppressing Wnt/β-Catenin Signaling

Wang Q, Liao J, He Z, Su Y, Lin D, Xu L, Xu H, Lin J

OncoTargets and Therapy 2020, 13:10983-10994

Published Date: 28 October 2020

Original Research

MiR-26a-5p Serves as an Oncogenic MicroRNA in Non-Small Cell Lung Cancer by Targeting FAF1

Ye M, Lin D, Li W, Xu H, Zhang J

Cancer Management and Research 2020, 12:7131-7142

Published Date: 11 August 2020

Original Research

Conformance Assessment of PD-L1 Expression Between Primary Tumour and Nodal Metastases in Non-Small-Cell Lung Cancer

Xu H, Chen X, Lin D, Zhang J, Li C, Zhang D, Zhang X

OncoTargets and Therapy 2019, 12:11541-11547

Published Date: 30 December 2019